Sponsor Pipeline

Shanghai IASO Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT07483346
IASO-782 in Systemic Lupus Erythematosus		 Recruitment opened
2026-08-11 NCT07483346
IASO-782 in Systemic Lupus Erythematosus		 Trial sites expanded: 0 -> 4 locations
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06534021 IASO-782 in Autoimmune Hematological Diseases Autoimmune Thrombocytopenia Recruiting
NCT07483346 IASO-782 in Systemic Lupus Erythematosus SLE - Systemic Lupus Erythematosus Recruiting
Disease Areas
Lupus (SLE) (1)
Get alerts when Shanghai IASO Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free